Showing results (1391-1400 of 7,005) with videos related to
Sort By:
Pageof 701
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.Cancer Science|April 5, 2019
Tumor necrosis factor receptor-associated factor 6 contributes to malignant behavior of human cancers through promoting AKT ubiquitination and phosphorylationJianbo Shi, Zengying Liu, Qin XuCancer Science|July 27, 2019
Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open-label phase 2 trialKenji Tamura, Kosei Hasegawa, Noriyuki Katsumata, et al.Cancer Science|July 27, 2019
Silent mating-type information regulation 2 homolog 1 overexpression is an important strategy for the survival of adapted suspension tumor cellsJi Young Park, Sora Han, Hye In Ka, et al.Cancer Science|April 4, 2019
LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expressionWeimin Wu, Hao Gao, Xiaofeng Li, et al.Cancer Science|April 6, 2019
Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinomaJiejie Qin, Shuaibing Wang, Jianxiang Shi, et al.Cancer Science|March 4, 2017
Metabolic characterization of invaded cells of the pancreatic cancer cell line, PANC-1Mayumi Fujita, Kaori Imadome, Takashi ImaiCancer Science|March 8, 2017
Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanomaNaoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara, et al.Cancer Science|March 8, 2017
Phase 1 study of OCV-C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancerHiroya Taniguchi, Satoru Iwasa, Kentaro Yamazaki, et al.Cancer Science|March 8, 2017
Recent advances in genetic modification of adenovirus vectors for cancer treatmentYuki Yamamoto, Masaki Nagasato, Teruhiko Yoshida, et al.Pageof 701